Scientific innovation continues to redefine the possibilities of vaccination, immune therapeutics, and preventive healthcare. The Global Vaccines Innovation and Immunology Conference (GVX Immunology 2026) will unite an international community of experts from September 21–23, 2026, in London, United Kingdom, while extending online, hybrid, and virtual participation for delegates worldwide. Designed to encourage multidisciplinary collaboration, the Vaccine Conference 2026 welcomes researchers, clinicians, immunologists, microbiologists, pharmaceutical scientists, biotechnology professionals, epidemiologists, healthcare providers, academic leaders, and postgraduate students. Attendees can learn about advances in vaccine engineering, immune signaling, cellular therapies, computational immunology, precision medicine, vaccine manufacturing, infectious disease surveillance, immunotoxicology, therapeutic vaccines, and biomarker research. An international gathering of specialists from universities, hospitals, biotechnology companies, pharmaceutical industries, research laboratories, and government institutions creates valuable opportunities for networking and collaboration. Participants can exchange practical knowledge, identify research partners, and discuss scientific developments that support future healthcare innovations. The digital Immunology Congress platform enables remote delegates to participate in keynote lectures, expert presentations, scientific discussions, and educational programmes without travel restrictions. This flexible approach expands access to high-quality scientific content while encouraging continuous professional engagement.

Description supplied by the event organiser.